Galapagos | GLPG - Cost Of Sales

Galapagos reported EUR2.39M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
AstraZeneca AZN:LN USD 2.51B 393M
Biogen BIIB:US USD 570.9M 101.4M
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Hikma Pharmaceutical HIK:LN USD 662M 72M
Merck MRK:GR EUR 2.28B 137M
Neurocrine Biosciences NBIX:US USD 7.7M 1.6M
Novartis NOVN:VX USD 3.84B 180M
Roche Holding ROG:VX 8.95B 613M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M
YTE INCY:US USD 53.76M 4.48M